Insights from 2023 ASH Annual Meeting
T

AML and MDS Highlights & Key Takeaways

By Insights from 2023 ASH Annual Meeting FEATURING Talha Badar
By Insights from 2023 ASH Annual Meeting FEATURING Talha Badar
2,078 views
January 24, 2024
1 Comment
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Related Content

AUTOPLAY
11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
27:49
Insights from 2024 EHA Annual Meeting

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Feat. T. Badar
17:51
Indy Hematology Review

Treatment of AML: Managing the Patient When Transplant Is Not an Opt…

Feat. H. Erba
31:53
Indy Hematology Review

HSCT in 2024: What Every Hematologist Needs to Know

Feat. R. Childs
19:21
SOHO Brazil 2024

Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde

Feat. J. Lancet
19:01
XV Eurasian Hematology-Oncology Congress - EHOC 2024

Debates in AML: 7+3 Is No Longer the Standard of Care

Feat. T. Kadia
27:26
SOHO Brazil 2024

Where I Use Azacitidine and Venetoclax in AML: Present and Future

Feat. J. Lancet
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
21:51
MyCancerHaven

Experts Discuss the Pathophysiology, Diagnosis, and Treatment of BPD…

Feat. R. Vij, G. Murthy
28:02
University of Colorado Division of Hematology

2024 Updates in AML

Feat. C. McMahon
09:51
i3 Health

MRD Testing in Leukemias: When Negativity Is a Positive Thing

Feat. N. S. Raje
22:30
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Emerging Treatment Options for AML in 2024

Feat. A. Perl
14:32
Vanderbilt University Medical Center (VUMC)

Summary of Recent Updates in MDS

Feat. S. Ball
04:16
UChicago Medicine 12th International Clinical Cancer Genomics Conference

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

Feat. L. Banaszak
02:01
Emanuele Angelucci

Administration and Dosing of Tagraxofusp for BPDCN

13:51
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

ALL in Adults: Overview and Recent Advances

Feat. R. Cassaday
11:35
Vanderbilt University Medical Center (VUMC)

Prevention and Management of Post-SCT Relapse in Acute Leukemias

Feat. A. Jallouk
16:28
Fred Hutchinson Cancer Center

Blinatumomab for Ph- ALL in First MRD-Negative Remission: E1910 and …

Feat. R. Cassaday
14:01
2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Summary: Highlights in Heme Malignancies

Feat. M. Gomes da Silva